Viemed Healthcare, Inc. (VMD)
NASDAQ: VMD · Real-Time Price · USD
10.05
+0.17 (1.72%)
At close: Apr 28, 2026, 4:00 PM EDT
9.95
-0.10 (-1.00%)
After-hours: Apr 28, 2026, 7:29 PM EDT

Company Description

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States.

The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment.

In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines.

Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services.

Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Viemed Healthcare, Inc.
Viemed Healthcare logo
Country United States
Founded 2006
Industry Medical Devices
Sector Healthcare
Employees 1,382
CEO Casey Hoyt

Contact Details

Address:
625 East Kaliste Saloom Road
Lafayette, Louisiana 70508
United States
Phone 337 504 3802
Website viemed.com

Stock Details

Ticker Symbol VMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001729149
CUSIP Number 92663R105
ISIN Number CA92663R1055
SIC Code 8090

Key Executives

Name Position
Casey Hoyt Chief Executive Officer and Director
Michael B. Moore CRT President
Trae Paul Fitzgerald Chief Financial Officer
William Todd Zehnder Chief Operating Officer and Director
Jeremy Trahan General Counsel and Corporate Secretary
Dr. William Dana Frazier M.D. Chief Medical Officer and Director
Jerome Richard Cambre II Vice President of Sales
Michael Freeman Chief Business Development Officer

Latest SEC Filings

Date Type Title
Apr 22, 2026 DEF 14A Other definitive proxy statements
Apr 22, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 22, 2026 ARS Filing
Mar 20, 2026 144 Filing
Mar 19, 2026 144 Filing
Mar 18, 2026 144 Filing
Mar 16, 2026 8-K Current Report
Mar 4, 2026 10-K Annual Report
Mar 4, 2026 8-K Current Report
Nov 7, 2025 SCHEDULE 13G/A Filing